Rimidi’s cardiometabolic platform supports disease management of some of the most prevalent and costly chronic conditions. The platform provides access to the tools required to manage multiple disease states – Diabetes, Cardiovascular Disease/Hypertension, Heart Failure, Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH), and Obesity. The platform consolidates relevant clinical data from the EMR for each disease state with patient-generated health data from connected devices or surveys, and layers clinical decision support that can be mapped against national or practice guidelines. Our cardiometabolic snapshot allows clinicians to quickly assess patient status for each comorbid disease state -- are screenings up to date? Are key metrics well-controlled?
Browse options below. Based on data from AVIA reviews and gathered information about the vendor's clients, you can see how Rimidi Cardiometabolic Management Platform stacks up to the competition. Check reviews from current & previous users at organizations like yours to find the best product for your you organization.